Patrick Mallon to Clinical Trials, Phase II as Topic
This is a "connection" page, showing publications Patrick Mallon has written about Clinical Trials, Phase II as Topic.
Connection Strength
0.165
-
The COVIRL002 Trial-Tocilizumab for management of severe, non-critical COVID-19 infection: A structured summary of a study protocol for a randomised controlled trial. Trials. 2020 Sep 03; 21(1):758.
Score: 0.165